Immunome Inc (IMNM)
15.75
+0.78
(+5.21%)
USD |
NASDAQ |
May 03, 16:00
16.05
+0.30
(+1.90%)
After-Hours: 20:00
Immunome Price to Book Value: 7.843 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 7.843 |
| May 02, 2024 | 7.454 |
| May 01, 2024 | 7.315 |
| April 30, 2024 | 7.001 |
| April 29, 2024 | 6.882 |
| April 26, 2024 | 6.837 |
| April 25, 2024 | 7.101 |
| April 24, 2024 | 7.106 |
| April 23, 2024 | 7.300 |
| April 22, 2024 | 7.608 |
| April 19, 2024 | 7.708 |
| April 18, 2024 | 8.555 |
| April 17, 2024 | 8.654 |
| April 16, 2024 | 9.162 |
| April 15, 2024 | 9.386 |
| April 12, 2024 | 10.25 |
| April 11, 2024 | 10.47 |
| April 10, 2024 | 10.12 |
| April 09, 2024 | 10.20 |
| April 08, 2024 | 10.03 |
| April 05, 2024 | 10.09 |
| April 04, 2024 | 10.09 |
| April 03, 2024 | 10.76 |
| April 02, 2024 | 10.65 |
| April 01, 2024 | 11.01 |
| Date | Value |
|---|---|
| March 28, 2024 | 12.29 |
| March 27, 2024 | 12.71 |
| March 26, 2024 | 12.64 |
| March 25, 2024 | 11.88 |
| March 22, 2024 | 11.60 |
| March 21, 2024 | 11.51 |
| March 20, 2024 | 11.50 |
| March 19, 2024 | 11.48 |
| March 18, 2024 | 10.54 |
| March 15, 2024 | 10.72 |
| March 14, 2024 | 10.70 |
| March 13, 2024 | 11.30 |
| March 12, 2024 | 11.61 |
| March 11, 2024 | 11.28 |
| March 08, 2024 | 12.69 |
| March 07, 2024 | 13.04 |
| March 06, 2024 | 12.56 |
| March 05, 2024 | 12.00 |
| March 04, 2024 | 11.80 |
| March 01, 2024 | 12.14 |
| February 29, 2024 | 11.54 |
| February 28, 2024 | 11.66 |
| February 27, 2024 | 12.40 |
| February 26, 2024 | 11.84 |
| February 23, 2024 | 11.26 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.7173
Minimum
May 13 2022
75.46
Maximum
Dec 28 2023
8.684
Average
4.026
Median
Price to Book Value Benchmarks
| Ayala Pharmaceuticals Inc | -- |
| Tenax Therapeutics Inc | 0.9285 |
| GE HealthCare Technologies Inc | 4.897 |
| Exelixis Inc | 2.998 |
| Puma Biotechnology Inc | 4.384 |
Price to Book Value Related Metrics
| PS Ratio | 22.42 |
| Price | 15.75 |
| Earnings Yield | -21.03% |
| Market Cap | 940.18M |